{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:08:37Z","timestamp":1793261317859,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1093017"],"award-info":[{"award-number":["1093017"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1111678"],"award-info":[{"award-number":["1111678"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1139071"],"award-info":[{"award-number":["1139071"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Uveal melanoma (UM) is the most common intraocular tumour in adults and despite surgical or radiation treatment of primary tumours, ~50% of patients progress to metastatic disease. Therapeutic options for metastatic UM are limited, with clinical trials having little impact. Here we perform whole-genome sequencing (WGS) of 103 UM from all sites of the uveal tract (choroid, ciliary body, iris). While most UM have low tumour mutation burden (TMB), two subsets with high TMB are seen; one driven by germline\n                    <jats:italic>MBD4<\/jats:italic>\n                    mutation, and another by ultraviolet radiation (UVR) exposure, which is restricted to iris UM. All but one tumour have a known UM driver gene mutation (\n                    <jats:italic>GNAQ, GNA11, BAP1, PLCB4, CYSLTR2, SF3B1, EIF1AX<\/jats:italic>\n                    ). We identify three other significantly mutated genes (\n                    <jats:italic>TP53<\/jats:italic>\n                    ,\n                    <jats:italic>RPL5<\/jats:italic>\n                    and\n                    <jats:italic>CENPE<\/jats:italic>\n                    ).\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-16276-8","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T06:05:00Z","timestamp":1589522700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":149,"title":["Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours"],"prefix":"10.1038","volume":"11","author":[{"given":"Peter A.","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicity","family":"Newell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2702-522X","authenticated-orcid":false,"given":"Jane M.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Wilmott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia L.","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Broit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo S.","family":"Carlino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambros T.","family":"Koufariotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7201-6819","authenticated-orcid":false,"given":"Vaishnavi","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5727-7463","authenticated-orcid":false,"given":"Aaron B.","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Howlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2094-9198","authenticated-orcid":false,"given":"Helen","family":"Rizos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3955-5076","authenticated-orcid":false,"given":"Chris W.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina V.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1054-1460","authenticated-orcid":false,"given":"Jens F.","family":"Kiilgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8613-3570","authenticated-orcid":false,"given":"Elin S.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia J.","family":"Rolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham J.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8991-0013","authenticated-orcid":false,"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"van Baren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3950-2476","authenticated-orcid":false,"given":"Nicola","family":"Waddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2882-6798","authenticated-orcid":false,"given":"Karin W.","family":"Wadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0925-1124","authenticated-orcid":false,"given":"Lindsay A.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K.","family":"Warrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Glasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4760-1033","authenticated-orcid":false,"given":"Nicholas K.","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"16276_CR1","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1001\/jamaophthalmol.2015.0887","volume":"133","author":"AM Lane","year":"2015","unstructured":"Lane, A. M., Kim, I. K. & Gragoudas, E. S. Long-term risk of melanoma-related mortality for patients with uveal melanoma treated with proton beam therapy. JAMA Ophthalmol. 133, 792\u2013796 (2015).","journal-title":"JAMA Ophthalmol."},{"key":"16276_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/jamaophthalmol.2014.77","volume":"132","author":"BE Damato","year":"2014","unstructured":"Damato, B. E., Heimann, H., Kalirai, H. & Coupland, S. E. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival. JAMA Ophthalmol. 132, 605\u2013613 (2014).","journal-title":"JAMA Ophthalmol."},{"key":"16276_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1586\/17469872.3.5.569","volume":"3","author":"B Zbytek","year":"2008","unstructured":"Zbytek, B. et al. Current concepts of metastasis in melanoma. Expert Rev. Dermatol. 3, 569\u2013585 (2008).","journal-title":"Expert Rev. Dermatol."},{"key":"16276_CR4","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1167\/iovs.08-3165","volume":"50","author":"B Damato","year":"2009","unstructured":"Damato, B. et al. Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Investigative Ophthalmol. Vis. Sci. 50, 3048\u20133055 (2009).","journal-title":"Investigative Ophthalmol. Vis. Sci."},{"key":"16276_CR5","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-04-1750","volume":"64","author":"MD Onken","year":"2004","unstructured":"Onken, M. D., Worley, L. A., Ehlers, J. P. & Harbour, J. W. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 64, 7205\u20137209 (2004).","journal-title":"Cancer Res."},{"key":"16276_CR6","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.ophtha.2016.01.023","volume":"123","author":"S Yavuzyigitoglu","year":"2016","unstructured":"Yavuzyigitoglu, S. et al. Uveal melanomas with SF3B1 mutations: a distinct subclass associated with late-onset metastases. Ophthalmology 123, 1118\u20131128 (2016).","journal-title":"Ophthalmology"},{"key":"16276_CR7","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.ophtha.2019.04.027","volume":"126","author":"P Vichitvejpaisal","year":"2019","unstructured":"Vichitvejpaisal, P. et al. Genetic analysis of uveal melanoma in 658 patients using the cancer genome atlas classification of uveal melanoma as A, B, C, and D. Ophthalmology 126, 1445\u20131453 (2019).","journal-title":"Ophthalmology"},{"key":"16276_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","volume":"32","author":"AG Robertson","year":"2017","unstructured":"Robertson, A. G. et al. Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell 32, 204\u2013220.e215 (2017).","journal-title":"Cancer Cell"},{"key":"16276_CR9","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.ajhg.2016.09.008","volume":"99","author":"B Royer-Bertrand","year":"2016","unstructured":"Royer-Bertrand, B. et al. Comprehensive genetic landscape of uveal melanoma by whole-genome sequencing. Am. J. Hum. Genet. 99, 1190\u20131198 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"16276_CR10","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","volume":"3","author":"SJ Furney","year":"2013","unstructured":"Furney, S. J. et al. SF3B1 mutations are associated with alternative splicing in uveal melanoma. Cancer Discov. 3, 1122\u20131129 (2013).","journal-title":"Cancer Discov."},{"key":"16276_CR11","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.18632\/oncotarget.6614","volume":"7","author":"P Johansson","year":"2016","unstructured":"Johansson, P. et al. Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4. Oncotarget 7, 4624\u20134631 (2016).","journal-title":"Oncotarget"},{"key":"16276_CR12","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1167\/iovs.06-0101","volume":"47","author":"E Kilic","year":"2006","unstructured":"Kilic, E. et al. Clinical and cytogenetic analyses in uveal melanoma. Investigative Ophthalmol. Vis. Sci. 47, 3703\u20133707 (2006).","journal-title":"Investigative Ophthalmol. Vis. Sci."},{"key":"16276_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"16276_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00251-019-01108-x","volume":"71","author":"PA Johansson","year":"2019","unstructured":"Johansson, P. A. et al. Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab. Immunogenetics 71, 433\u2013436 (2019).","journal-title":"Immunogenetics"},{"key":"16276_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04322-5","volume":"9","author":"M Rodrigues","year":"2018","unstructured":"Rodrigues, M. et al. Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors. Nat. Commun. 9, 1866 (2018).","journal-title":"Nat. Commun."},{"key":"16276_CR16","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ophtha.2005.04.020","volume":"112","author":"CP Shah","year":"2005","unstructured":"Shah, C. P., Weis, E., Lajous, M., Shields, J. A. & Shields, C. L. Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis. Ophthalmology 112, 1599\u20131607 (2005).","journal-title":"Ophthalmology"},{"key":"16276_CR17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","volume":"23","author":"A Zehir","year":"2017","unstructured":"Zehir, A. et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat. Med. 23, 703\u2013713 (2017).","journal-title":"Nat. Med."},{"key":"16276_CR18","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/PAS.0000000000001110","volume":"42","author":"NM Joseph","year":"2018","unstructured":"Joseph, N. M. et al. Frequent GNAQ and GNA14 mutations in hepatic small vessel neoplasm. Am. J. surgical Pathol. 42, 1201\u20131207 (2018).","journal-title":"Am. J. surgical Pathol."},{"key":"16276_CR19","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1097\/PAS.0000000000000645","volume":"40","author":"JA van de Nes","year":"2016","unstructured":"van de Nes, J. A. et al. Comparing the prognostic value of BAP1 mutation pattern, chromosome 3 status, and BAP1 immunohistochemistry in uveal melanoma. Am. J. Surgical Pathol. 40, 796\u2013805 (2016).","journal-title":"Am. J. Surgical Pathol."},{"key":"16276_CR20","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour, J. W. et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330, 1410\u20131413 (2010).","journal-title":"Science"},{"key":"16276_CR21","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/ng.2674","volume":"45","author":"M Martin","year":"2013","unstructured":"Martin, M. et al. Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat. Genet. 45, 933\u2013936 (2013).","journal-title":"Nat. Genet."},{"key":"16276_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.15252\/embr.201541143","volume":"17","author":"MA Tame","year":"2016","unstructured":"Tame, M. A., Raaijmakers, J. A., Afanasyev, P. & Medema, R. H. Chromosome misalignments induce spindle-positioning defects. EMBO Rep. 17, 317\u2013325 (2016).","journal-title":"EMBO Rep."},{"key":"16276_CR23","doi-asserted-by":"publisher","first-page":"10084","DOI":"10.1074\/jbc.RA118.003154","volume":"293","author":"G Ciossani","year":"2018","unstructured":"Ciossani, G. et al. The kinetochore proteins CENP-E and CENP-F directly and specifically interact with distinct BUB mitotic checkpoint Ser\/Thr kinases. J. Biol. Chem. 293, 10084\u201310101 (2018).","journal-title":"J. Biol. Chem."},{"key":"16276_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19744-w","volume":"8","author":"KT Chang","year":"2018","unstructured":"Chang, K. T., Guo, J., di Ronza, A. & Sardiello, M. Aminode: identification of evolutionary constraints in the human proteome. Sci. Rep. 8, 1357 (2018).","journal-title":"Sci. Rep."},{"key":"16276_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1083\/jcb.143.1.49","volume":"143","author":"GK Chan","year":"1998","unstructured":"Chan, G. K., Schaar, B. T. & Yen, T. J. Characterization of the kinetochore binding domain of CENP-E reveals interactions with the kinetochore proteins CENP-F and hBUBR1. J. cell Biol. 143, 49\u201363 (1998).","journal-title":"J. cell Biol."},{"key":"16276_CR26","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/35019518","volume":"2","author":"X Yao","year":"2000","unstructured":"Yao, X., Abrieu, A., Zheng, Y., Sullivan, K. F. & Cleveland, D. W. CENP-E forms a link between attachment of spindle microtubules to kinetochores and the mitotic checkpoint. Nat. Cell Biol. 2, 484\u2013491 (2000).","journal-title":"Nat. Cell Biol."},{"key":"16276_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0092-8674(03)00475-6","volume":"114","author":"Y Mao","year":"2003","unstructured":"Mao, Y., Abrieu, A. & Cleveland, D. W. Activating and silencing the mitotic checkpoint through CENP-E-dependent activation\/inactivation of BubR1. Cell 114, 87\u201398 (2003).","journal-title":"Cell"},{"key":"16276_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ccr.2006.12.003","volume":"11","author":"BA Weaver","year":"2007","unstructured":"Weaver, B. A., Silk, A. D., Montagna, C., Verdier-Pinard, P. & Cleveland, D. W. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11, 25\u201336 (2007).","journal-title":"Cancer Cell"},{"key":"16276_CR29","doi-asserted-by":"publisher","first-page":"10103","DOI":"10.1158\/0008-5472.CAN-07-2266","volume":"67","author":"BA Weaver","year":"2007","unstructured":"Weaver, B. A. & Cleveland, D. W. Aneuploidy: instigator and inhibitor of tumorigenesis. Cancer Res. 67, 10103\u201310105 (2007).","journal-title":"Cancer Res."},{"key":"16276_CR30","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.2147\/OTT.S136785","volume":"10","author":"H Liu","year":"2017","unstructured":"Liu, H. & Zhou, M. Evaluation of p53 gene expression and prognosis characteristics in uveal melanoma cases. OncoTargets Ther. 10, 3429\u20133434 (2017).","journal-title":"OncoTargets Ther."},{"key":"16276_CR31","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0002-9440(10)64817-1","volume":"157","author":"MA Brantley Jr.","year":"2000","unstructured":"Brantley, M. A. Jr. & Harbour, J. W. Deregulation of the Rb and p53 pathways in uveal melanoma. Am. J. Pathol. 157, 1795\u20131801 (2000).","journal-title":"Am. J. Pathol."},{"key":"16276_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4161\/cbt.4.1.1373","volume":"4","author":"MR Hussein","year":"2005","unstructured":"Hussein, M. R. The relationships between p53 protein expression and the clinicopathological features in the uveal melanomas. Cancer Biol. Ther. 4, 57\u201359 (2005).","journal-title":"Cancer Biol. Ther."},{"key":"16276_CR33","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1158\/1078-0432.CCR-19-1215","volume":"25","author":"M Rodrigues","year":"2019","unstructured":"Rodrigues, M. et al. Evolutionary routes in metastatic uveal melanomas depend on MBD4 alterations. Clin. Cancer Res. 25, 5513\u20135524 (2019).","journal-title":"Clin. Cancer Res."},{"key":"16276_CR34","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/bioinformatics\/btt182","volume":"29","author":"HA Shihab","year":"2013","unstructured":"Shihab, H. A., Gough, J., Cooper, D. N., Day, I. N. & Gaunt, T. R. Predicting the functional consequences of cancer-associated amino acid substitutions. Bioinformatics 29, 1504\u20131510 (2013).","journal-title":"Bioinformatics"},{"key":"16276_CR35","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41588-018-0204-y","volume":"50","author":"AO Giacomelli","year":"2018","unstructured":"Giacomelli, A. O. et al. Mutational processes shape the landscape of TP53 mutations in human cancer. Nat. Genet. 50, 1381\u20131387 (2018).","journal-title":"Nat. Genet."},{"key":"16276_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.molcel.2018.06.012","volume":"71","author":"E Kotler","year":"2018","unstructured":"Kotler, E. et al. A systematic p53 mutation library links differential functional impact to cancer mutation pattern and evolutionary conservation. Mol. Cell 71, 178\u2013190 e178 (2018).","journal-title":"Mol. Cell"},{"key":"16276_CR37","doi-asserted-by":"publisher","first-page":"a001107","DOI":"10.1101\/cshperspect.a001107","volume":"2","author":"M Oren","year":"2010","unstructured":"Oren, M. & Rotter, V. Mutant p53 gain-of-function in cancer. Cold Spring Harb. Perspect. Biol. 2, a001107 (2010).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"16276_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2220\/biomedres.31.401","volume":"31","author":"K Yoshikawa","year":"2010","unstructured":"Yoshikawa, K. et al. Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells. Biomed. Res. 31, 401\u2013411 (2010).","journal-title":"Biomed. Res."},{"key":"16276_CR39","doi-asserted-by":"publisher","first-page":"14462","DOI":"10.18632\/oncotarget.14895","volume":"8","author":"L Fancello","year":"2017","unstructured":"Fancello, L., Kampen, K. R., Hofman, I. J., Verbeeck, J. & De Keersmaecker, K. The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types. Oncotarget 8, 14462\u201314478 (2017).","journal-title":"Oncotarget"},{"key":"16276_CR40","doi-asserted-by":"publisher","first-page":"44475","DOI":"10.1074\/jbc.M403722200","volume":"279","author":"MS Dai","year":"2004","unstructured":"Dai, M. S. & Lu, H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J. Biol. Chem. 279, 44475\u201344482 (2004).","journal-title":"J. Biol. Chem."},{"key":"16276_CR41","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.celrep.2013.08.049","volume":"5","author":"KE Sloan","year":"2013","unstructured":"Sloan, K. E., Bohnsack, M. T. & Watkins, N. J. The 5S RNP couples p53 homeostasis to ribosome biogenesis and nucleolar stress. Cell Rep. 5, 237\u2013247 (2013).","journal-title":"Cell Rep."},{"key":"16276_CR42","doi-asserted-by":"publisher","first-page":"25812","DOI":"10.1074\/jbc.M109.098442","volume":"285","author":"XX Sun","year":"2010","unstructured":"Sun, X. X., Wang, Y. G., Xirodimas, D. P. & Dai, M. S. Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation. J. Biol. Chem. 285, 25812\u201325821 (2010).","journal-title":"J. Biol. Chem."},{"key":"16276_CR43","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrc2819","volume":"10","author":"J van Riggelen","year":"2010","unstructured":"van Riggelen, J., Yetil, A. & Felsher, D. W. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat. Rev. Cancer 10, 301\u2013309 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"16276_CR44","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1158\/0008-5472.CAN-18-2718","volume":"79","author":"C Morcelle","year":"2019","unstructured":"Morcelle, C. et al. Oncogenic MYC induces the impaired ribosome biogenesis checkpoint and stabilizes p53 independent of increased ribosome content. Cancer Res. 79, 4348\u20134359 (2019).","journal-title":"Cancer Res."},{"key":"16276_CR45","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1038\/onc.2013.430","volume":"33","author":"JM Liao","year":"2014","unstructured":"Liao, J. M., Zhou, X., Gatignol, A. & Lu, H. Ribosomal proteins L5 and L11 co-operatively inactivate c-Myc via RNA-induced silencing complex. Oncogene 33, 4916\u20134923 (2014).","journal-title":"Oncogene"},{"key":"16276_CR46","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1128\/MCB.05810-11","volume":"31","author":"KB Challagundla","year":"2011","unstructured":"Challagundla, K. B. et al. Ribosomal protein L11 recruits miR-24\/miRISC to repress c-Myc expression in response to ribosomal stress. Mol. Cell. Biol. 31, 4007\u20134021 (2011).","journal-title":"Mol. Cell. Biol."},{"key":"16276_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi, N. A. et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124\u2013128 (2015).","journal-title":"Science"},{"key":"16276_CR48","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0161-6420(00)00449-8","volume":"108","author":"CL Shields","year":"2001","unstructured":"Shields, C. L. et al. Iris melanoma: risk factors for metastasis in 169 consecutive patients. Ophthalmology 108, 172\u2013178 (2001).","journal-title":"Ophthalmology"},{"key":"16276_CR49","doi-asserted-by":"publisher","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. https:\/\/doi.org\/10.14806\/ej.17.1.200 (2011).","DOI":"10.14806\/ej.17.1.200"},{"key":"16276_CR50","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"16276_CR51","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"16276_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"16276_CR53","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward, N. K. et al. Whole-genome landscapes of major melanoma subtypes. Nature 545, 175\u2013180 (2017).","journal-title":"Nature"},{"key":"16276_CR54","doi-asserted-by":"publisher","first-page":"e74380","DOI":"10.1371\/journal.pone.0074380","volume":"8","author":"KS Kassahn","year":"2013","unstructured":"Kassahn, K. S. et al. Somatic point mutation calling in low cellularity tumors. PLoS ONE 8, e74380 (2013).","journal-title":"PLoS ONE"},{"key":"16276_CR55","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"16276_CR56","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nmeth.2642","volume":"10","author":"A Gonzalez-Perez","year":"2013","unstructured":"Gonzalez-Perez, A. et al. IntOGen-mutations identifies cancer drivers across tumor types. Nat. Methods 10, 1081\u20131082 (2013).","journal-title":"Nat. Methods"},{"key":"16276_CR57","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/humu.23035","volume":"37","author":"L Bouaoun","year":"2016","unstructured":"Bouaoun, L. et al. TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data. Hum. Mutat. 37, 865\u2013876 (2016).","journal-title":"Hum. Mutat."},{"key":"16276_CR58","doi-asserted-by":"publisher","first-page":"16910","DOI":"10.1073\/pnas.1009843107","volume":"107","author":"P Van Loo","year":"2010","unstructured":"Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA 107, 16910\u201316915 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16276-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16276-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16276-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T17:01:05Z","timestamp":1670259665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16276-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["16276"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-16276-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,15]]},"assertion":[{"value":"2 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.V.P. and N.W. are founders and shareholders of genomiQa Pty Ltd, and members of its Board. K.W.W. participated in one Advisory board meeting for MSD and AstraZeneca. R.A.S. receives fees for professional services from Merck Sharp & Dohme, GlaxoSmithKline Australia, Bristol-Myers Squibb, Dermpedia, Novartis Pharmaceuticals Australia Pty Ltd, Myriad, NeraCare and Amgen. G.V.L. is consulant advisor for Aduro, Amgen, Array, BMS, MERCK MSD, Novartis, Pierre-Fabre, Roche. None of these relationships involve the work described in this manuscript. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2408"}}